Maan Aluminium Q2 FY27: PAT sinks 85% YoY to ₹0.89 Cr as trading margins collapse
PAT -84.58% YoY · revenue +46.26% · margins compressing
₹279.48 Cr
+46.26% YoY
₹0.89 Cr
-84.58% YoY
0.32%
-2.7pp YoY
₹0.15
Maan Aluminium's standalone Q2 FY27 (quarter ended Sep 30, 2026) revenue from operations rose 46.3% YoY to ₹279.48 Cr (+20.5% QoQ from ₹231.86 Cr), but net profit collapsed 84.6% YoY to ₹0.89 Cr (EPS ₹0.15) from ₹5.77 Cr (EPS ₹1.07) a year ago, and fell 71.3% QoQ from ₹3.10 Cr (EPS ₹0.52). PBT was just ₹1.25 Cr versus ₹7.77 Cr a year ago. Neither period carries an exceptional item, so this is a purely operational decline, not an accounting one-off — no raw-vs-adjusted split is needed.
Q2 FY-2027 vs prior quarters
The squeeze sits almost entirely in the trading book: Purchase of stock-in-trade grew 86.1% YoY to ₹182.46 Cr, far outrunning the 46.3% revenue growth, while cost of materials consumed — the line tied to the manufacturing business — rose only 8.0% YoY (₹65.09 Cr to ₹70.27 Cr), broadly consistent with management's own framing of manufacturing as flattish. EBITDA margin (OPM) fell to 0.74% from 4.17% YoY and 2.32% QoQ; net margin fell to 0.32% from 3.02% YoY and 1.34% QoQ. Finance costs actually declined YoY (₹1.19 Cr vs ₹1.69 Cr), so financing costs are not the driver — the compression is a gross-margin problem in the trading segment.
The stock went into the print at ₹102.5, up 0.2% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
Results are standalone-only, limited-review (unaudited) figures — no consolidated statement was filed.
FY27 guidance is flattish on manufacturing revenue; ramp-up expected towards end of FY27/early FY28 as new capacities stabilize. Cumulative capex ~₹166 Cr over 3 years, with major spend in H2 FY27. Dewas plant (₹45 Cr capex) targeted to come online by mid-FY28 with asset turnover of 2-3x.
— This quarter: met
Management's August 2026 concall guided FY27 manufacturing revenue as flattish, with ramp-up only from late FY27/early FY28 as new capacity — including the ₹45 Cr Dewas plant targeted for mid-FY28 — stabilizes, alongside a ~₹166 Cr three-year capex plan weighted to H2 FY27; H1 FY27 capex on PP&E/WIP of ₹8.78 Cr (versus ₹4.47 Cr a year ago) is tracking that plan, so the manufacturing/capex guidance holds even as standalone profitability deteriorates for reasons outside its scope. No brokerage published a Q2 FY27 estimate for this stock, so vsStreet is unknown. Separately, working capital stretched: trade receivables rose 24.6% in six months to ₹113.06 Cr (from ₹90.73 Cr at FY26-end), pushing H1 FY27 operating cash flow to -₹36.28 Cr (from +₹14.17 Cr a year ago), a gap funded by short-term borrowings nearly doubling to ₹82.77 Cr.
W1
OPM trajectory — whether it recovers from 0.74% toward the 2-4% range seen in the last three quarters as the ₹45 Cr Dewas plant (guided for mid-FY28) comes online.
W2
Working capital — trade receivables (₹113.06 Cr) and H1 operating cash flow (-₹36.28 Cr); short-term borrowings (now ₹82.77 Cr) are funding the gap.
W3
H2 FY27 capex pacing against the ~₹166 Cr three-year plan management flagged as weighted to H2.
Standalone only — no consolidated statement filed; unaudited, limited-review (SRE 2410) figures. No exceptional items in current or comparative periods. PDF's plain-text layer had the 'changes in inventories' sub-line swapped between the Sep-26/Jun-26 columns versus the image-rendered table; resolved by tying both to the stated Total Expenses row — no impact on any reported P&L figure used here.